This inventor holds 1 USPTO granted patent. Top assignee: Technische Unversität Berlin. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Vanessa Brueckner: Innovator in Cancer Treatment
Introduction
Vanessa Brueckner is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of cancer treatment through her innovative research and patented methods. Her work focuses on utilizing a modified Coxsackievirus B3 variant to target cancer cells effectively.
Latest Patents
Brueckner holds a patent for a method for treating cancer with a Coxsackievirus B3 (CVB3) variant. The invention involves administering a therapeutically effective amount of the virus to a subject in need. This method specifically targets cancer cells that express a heparan sulfate (HS) receptor on their surface. The virus binds to the HS receptor, enters the cancer cells, and accumulates within them, leading to viral lysis of the cancer cells.
Career Highlights
Brueckner is affiliated with Technische Universität Berlin, where she conducts her research and develops her innovative treatments. Her work has garnered attention for its potential to revolutionize cancer therapy and improve patient outcomes.
Collaborations
Some of her notable coworkers include Henry Fechner and Ahmet Hazini. Their collaborative efforts contribute to the advancement of research in cancer treatment and the development of new therapeutic methods.
Conclusion
Vanessa Brueckner is a trailblazer in the field of cancer treatment, with her innovative approach utilizing a modified virus to target cancer cells. Her contributions are paving the way for new therapeutic options in oncology.